Mutations of notch3 in childhood pulmonary arterial hypertension

Ayako Chida, Masaki Shintani, Yoshihisa Matsushita, Hiroki Sato, Takahiro Eitoku, Tomotaka Nakayama, Yoshiyuki Furutani, Emiko Hayama, Yoichi Kawamura, Kei Inai, Shin-ichi Ohtsuki, Tsutomu Saji, Shigeaki Nonoyama, Toshio Nakanishi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Mutations of BMPR2 and other TGF-β superfamily genes have been reported in pulmonary arterial hypertension (PAH). However, 60–90% of idiopathic PAH cases have no mutations in these genes. Recently, the expression of NOTCH3 was shown to be increased in the pulmonary artery smooth muscle cells of PAH patients. We sought to investigate NOTCH3 and its target genes in PAH patients and clarify the role of NOTCH3 signaling. We screened for mutations in NOTCH3, HES1, and HES5 in 41 PAH patients who had no mutations in BMPR2, ALK1, endoglin, SMAD1/4/8, BMPR1B, or Caveolin-1. Two novel missense mutations (c.2519 G>A p.G840E, c.2698 A>C p.T900P) in NOTCH3 were identified in two PAH patients. We performed functional analysis using stable cell lines expressing either wild-type or mutant NOTCH3. The protein-folding chaperone GRP78/BiP was colocalized with wild-type NOTCH3 in the endoplasmic reticulum, whereas the majority of GRP78/BiP was translo-cated into the nuclei of cells expressing mutant NOTCH3. Cell proliferation and viability were higher for cells expressing mutant NOTCH3 than for those expressing wild-type NOTCH3. We identified novel NOTCH3 mutations in PAH patients and revealed that these mutations were involved in cell proliferation and viability. NOTCH3 mutants induced an impairment in NOTCH3-HES5 signaling. The results may contribute to the elucidation of PAH pathogenesis.

Original languageEnglish
Pages (from-to)229-239
Number of pages11
JournalMolecular Genetics and Genomic Medicine
Volume2
Issue number3
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Pulmonary Hypertension
Mutation
Cell Survival
Cell Proliferation
Genes
Caveolin 1
Protein Folding
Missense Mutation
Cell Nucleus
Endoplasmic Reticulum
Pulmonary Artery
Smooth Muscle Myocytes
Cell Line

Keywords

  • ER stress
  • Gene mutation
  • NOTCH3
  • Pulmonary arterial hypertension

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Genetics(clinical)

Cite this

Chida, A., Shintani, M., Matsushita, Y., Sato, H., Eitoku, T., Nakayama, T., ... Nakanishi, T. (2014). Mutations of notch3 in childhood pulmonary arterial hypertension. Molecular Genetics and Genomic Medicine, 2(3), 229-239. https://doi.org/10.1002/mgg3.58

Mutations of notch3 in childhood pulmonary arterial hypertension. / Chida, Ayako; Shintani, Masaki; Matsushita, Yoshihisa; Sato, Hiroki; Eitoku, Takahiro; Nakayama, Tomotaka; Furutani, Yoshiyuki; Hayama, Emiko; Kawamura, Yoichi; Inai, Kei; Ohtsuki, Shin-ichi; Saji, Tsutomu; Nonoyama, Shigeaki; Nakanishi, Toshio.

In: Molecular Genetics and Genomic Medicine, Vol. 2, No. 3, 01.01.2014, p. 229-239.

Research output: Contribution to journalArticle

Chida, A, Shintani, M, Matsushita, Y, Sato, H, Eitoku, T, Nakayama, T, Furutani, Y, Hayama, E, Kawamura, Y, Inai, K, Ohtsuki, S, Saji, T, Nonoyama, S & Nakanishi, T 2014, 'Mutations of notch3 in childhood pulmonary arterial hypertension', Molecular Genetics and Genomic Medicine, vol. 2, no. 3, pp. 229-239. https://doi.org/10.1002/mgg3.58
Chida, Ayako ; Shintani, Masaki ; Matsushita, Yoshihisa ; Sato, Hiroki ; Eitoku, Takahiro ; Nakayama, Tomotaka ; Furutani, Yoshiyuki ; Hayama, Emiko ; Kawamura, Yoichi ; Inai, Kei ; Ohtsuki, Shin-ichi ; Saji, Tsutomu ; Nonoyama, Shigeaki ; Nakanishi, Toshio. / Mutations of notch3 in childhood pulmonary arterial hypertension. In: Molecular Genetics and Genomic Medicine. 2014 ; Vol. 2, No. 3. pp. 229-239.
@article{0bd6038107f94f42829d8ca720e4f704,
title = "Mutations of notch3 in childhood pulmonary arterial hypertension",
abstract = "Mutations of BMPR2 and other TGF-β superfamily genes have been reported in pulmonary arterial hypertension (PAH). However, 60–90{\%} of idiopathic PAH cases have no mutations in these genes. Recently, the expression of NOTCH3 was shown to be increased in the pulmonary artery smooth muscle cells of PAH patients. We sought to investigate NOTCH3 and its target genes in PAH patients and clarify the role of NOTCH3 signaling. We screened for mutations in NOTCH3, HES1, and HES5 in 41 PAH patients who had no mutations in BMPR2, ALK1, endoglin, SMAD1/4/8, BMPR1B, or Caveolin-1. Two novel missense mutations (c.2519 G>A p.G840E, c.2698 A>C p.T900P) in NOTCH3 were identified in two PAH patients. We performed functional analysis using stable cell lines expressing either wild-type or mutant NOTCH3. The protein-folding chaperone GRP78/BiP was colocalized with wild-type NOTCH3 in the endoplasmic reticulum, whereas the majority of GRP78/BiP was translo-cated into the nuclei of cells expressing mutant NOTCH3. Cell proliferation and viability were higher for cells expressing mutant NOTCH3 than for those expressing wild-type NOTCH3. We identified novel NOTCH3 mutations in PAH patients and revealed that these mutations were involved in cell proliferation and viability. NOTCH3 mutants induced an impairment in NOTCH3-HES5 signaling. The results may contribute to the elucidation of PAH pathogenesis.",
keywords = "ER stress, Gene mutation, NOTCH3, Pulmonary arterial hypertension",
author = "Ayako Chida and Masaki Shintani and Yoshihisa Matsushita and Hiroki Sato and Takahiro Eitoku and Tomotaka Nakayama and Yoshiyuki Furutani and Emiko Hayama and Yoichi Kawamura and Kei Inai and Shin-ichi Ohtsuki and Tsutomu Saji and Shigeaki Nonoyama and Toshio Nakanishi",
year = "2014",
month = "1",
day = "1",
doi = "10.1002/mgg3.58",
language = "English",
volume = "2",
pages = "229--239",
journal = "Molecular genetics & genomic medicine",
issn = "2324-9269",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

TY - JOUR

T1 - Mutations of notch3 in childhood pulmonary arterial hypertension

AU - Chida, Ayako

AU - Shintani, Masaki

AU - Matsushita, Yoshihisa

AU - Sato, Hiroki

AU - Eitoku, Takahiro

AU - Nakayama, Tomotaka

AU - Furutani, Yoshiyuki

AU - Hayama, Emiko

AU - Kawamura, Yoichi

AU - Inai, Kei

AU - Ohtsuki, Shin-ichi

AU - Saji, Tsutomu

AU - Nonoyama, Shigeaki

AU - Nakanishi, Toshio

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Mutations of BMPR2 and other TGF-β superfamily genes have been reported in pulmonary arterial hypertension (PAH). However, 60–90% of idiopathic PAH cases have no mutations in these genes. Recently, the expression of NOTCH3 was shown to be increased in the pulmonary artery smooth muscle cells of PAH patients. We sought to investigate NOTCH3 and its target genes in PAH patients and clarify the role of NOTCH3 signaling. We screened for mutations in NOTCH3, HES1, and HES5 in 41 PAH patients who had no mutations in BMPR2, ALK1, endoglin, SMAD1/4/8, BMPR1B, or Caveolin-1. Two novel missense mutations (c.2519 G>A p.G840E, c.2698 A>C p.T900P) in NOTCH3 were identified in two PAH patients. We performed functional analysis using stable cell lines expressing either wild-type or mutant NOTCH3. The protein-folding chaperone GRP78/BiP was colocalized with wild-type NOTCH3 in the endoplasmic reticulum, whereas the majority of GRP78/BiP was translo-cated into the nuclei of cells expressing mutant NOTCH3. Cell proliferation and viability were higher for cells expressing mutant NOTCH3 than for those expressing wild-type NOTCH3. We identified novel NOTCH3 mutations in PAH patients and revealed that these mutations were involved in cell proliferation and viability. NOTCH3 mutants induced an impairment in NOTCH3-HES5 signaling. The results may contribute to the elucidation of PAH pathogenesis.

AB - Mutations of BMPR2 and other TGF-β superfamily genes have been reported in pulmonary arterial hypertension (PAH). However, 60–90% of idiopathic PAH cases have no mutations in these genes. Recently, the expression of NOTCH3 was shown to be increased in the pulmonary artery smooth muscle cells of PAH patients. We sought to investigate NOTCH3 and its target genes in PAH patients and clarify the role of NOTCH3 signaling. We screened for mutations in NOTCH3, HES1, and HES5 in 41 PAH patients who had no mutations in BMPR2, ALK1, endoglin, SMAD1/4/8, BMPR1B, or Caveolin-1. Two novel missense mutations (c.2519 G>A p.G840E, c.2698 A>C p.T900P) in NOTCH3 were identified in two PAH patients. We performed functional analysis using stable cell lines expressing either wild-type or mutant NOTCH3. The protein-folding chaperone GRP78/BiP was colocalized with wild-type NOTCH3 in the endoplasmic reticulum, whereas the majority of GRP78/BiP was translo-cated into the nuclei of cells expressing mutant NOTCH3. Cell proliferation and viability were higher for cells expressing mutant NOTCH3 than for those expressing wild-type NOTCH3. We identified novel NOTCH3 mutations in PAH patients and revealed that these mutations were involved in cell proliferation and viability. NOTCH3 mutants induced an impairment in NOTCH3-HES5 signaling. The results may contribute to the elucidation of PAH pathogenesis.

KW - ER stress

KW - Gene mutation

KW - NOTCH3

KW - Pulmonary arterial hypertension

UR - http://www.scopus.com/inward/record.url?scp=85032585874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032585874&partnerID=8YFLogxK

U2 - 10.1002/mgg3.58

DO - 10.1002/mgg3.58

M3 - Article

VL - 2

SP - 229

EP - 239

JO - Molecular genetics & genomic medicine

JF - Molecular genetics & genomic medicine

SN - 2324-9269

IS - 3

ER -